Search for: "Teva Pharmaceuticals"
Results 321 - 340
of 1,423
Sort by Relevance
|
Sort by Date
5 Dec 2018, 4:44 am
Teva Pharmaceuticals, in which the justices considered yesterday whether the “on sale” bar to the patentability of an invention is triggered by a sale in which the purchaser is required to keep the details of the invention confidential. [read post]
4 Dec 2018, 4:50 pm
Teva Pharmaceuticals brought the justices their first patent case of the year. [read post]
4 Dec 2018, 2:51 pm
Teva Pharmaceuticals USA, Inc., No. 17-1229. [read post]
4 Dec 2018, 1:28 pm
Teva Pharmaceuticals had a little bit of everything. [read post]
4 Dec 2018, 1:21 pm
Teva Pharmaceuticals USA Inc. [read post]
4 Dec 2018, 11:16 am
Teva Pharmaceuticals USA Inc. is also available. [read post]
4 Dec 2018, 10:34 am
It sought to obtain settlement agreement, licensing agreements and any other related agreements between King Pharmaceuticals , Meridian Technologies, Inc. and Pfizer, Inc., the respondents in the proceeding (collectively, the "Respondents") and Teva Pharmaceutical Industries, Ltd. [read post]
4 Dec 2018, 6:24 am
” USA Today reported Teva Pharmaceuticals issued the voluntary recall for “all lots of combination tablets featuring the drugs amlodipine and valsartan and another combo drug featuring amlodipine, valsartan, and hydrochlorothiazide. [read post]
4 Dec 2018, 4:09 am
Teva Pharmaceuticals, which asks whether the “on sale” bar to the patentability of an invention is triggered by a sale in which the purchaser is required to keep the details of the invention confidential. [read post]
2 Dec 2018, 9:00 am
Teva Pharmaceuticals USA Inc. [read post]
29 Nov 2018, 12:24 pm
Teva Pharmaceuticals.) [read post]
27 Nov 2018, 9:30 am
Teva Pharmaceuticals USA Inc. presents the next one of those cases. [read post]
27 Nov 2018, 9:05 am
Pharmacy Times reports Teva Pharmaceuticals has issued a voluntary recall in the United States of all lots of amlodipine/valsartan tablets and amlodipine valsartan/hydrochlorothiazide combination tablets. [read post]
23 Nov 2018, 8:03 pm
Teva Pharmaceuticals USA Inc. case beginning at 4:00 pm (Eastern) on December 4, 2018 at the American University Washington College of Law in Washington, DC. [read post]
31 Oct 2018, 5:09 pm
As I noted here, Allergan, Teva Pharmaceuticals, and Endo International (whose Par Pharmaceuticals unit is caught up in the investigation) – all three companies that have been identified by name in connection with the alleged generic drug price-fixing conspiracy – previously were hit with securities class action lawsuit related to the price-fixing investigation. [read post]
18 Oct 2018, 9:59 pm
Teva Pharmaceuticals International GmbH PTAB Petition: IPR2018-01710; filed September 28, 2018. [read post]
17 Oct 2018, 7:49 pm
The Federal Circuit found the district court committed no error in construing claim terms as non-limiting for nonobviousness purposes or in invalidating as obvious all asserted claims of the Copaxone patents, including a 40-milligram dosage three times per week (Teva Pharmaceuticals USA, Inc. v. [read post]
15 Oct 2018, 7:05 am
Justice Kavanaugh being seated prior to the second week of oral arguments in October means that most of the cases on the docket in the October Term will be heard by a complete Court of 9 Justices; thus avoiding the dreaded 4-4 split. [read post]
12 Oct 2018, 1:24 pm
Delaware of invalidity of claims:Plaintiffs-Appellants Teva Pharmaceuticals USA,Inc., Teva Pharmaceutical Industries, Ltd., Teva Neuroscience,Inc., and Yeda Research and Development Co. [read post]
12 Oct 2018, 7:50 am
Teva Pharmaceuticals, blocking patent arguments have arisen in the Federal Circuit primarily in the pharmaceutical patent context, and until now have largely been limited to undermining evidence of commercial success. [read post]
